RESUMEN
Regrettably, conventional chromatographic columns have immutable polarity, resulting in requirements of at least two columns with polarity difference and sophisticated mechanical switching valves, which hinders the development of "micro-smart" multidimensional tandem chromatography. In this work, light-driven polarity switching was realized in a single capillary column based on the reversible trans-cis isomerization of 4-[3-(triethoxysilyl)propoxy]azobenzene as the stationary phase under light irradiation, with the change in dipole moment. As a result, the stationary phase offers precise and dynamic control of polarity based on the cis-trans azobenzene ratio, which depends on irradiation wavelength and time. Thus, the continuous adjustment of polarity enables diversified chromatographic separation modes, for example, step-polarity gradient and polarity-conversion separation modes, taking advantage of the superior freedom of polarity switching in time and spatial dimensions. The photosensitive column also shows good reproducibility of polarity photoreversibility and high separation efficiency. The present study might offer brand new insight into developing miniaturization and intellectualization of multidimensional chromatography via designing smart responsive switching valves or stationary phases, besides mechanical means.
Asunto(s)
Cromatografía , Reproducibilidad de los ResultadosRESUMEN
Hepatitis B virus (HBV) is implicated in the pathogenesis of hepatocellular carcinoma, which has been found to be associated with TGF-beta signaling. Activin A is a TGF-ß family cytokine that exhibits cell proliferation inhibition on normal hepatocyte. How HBV-encoded X oncoprotein play in activin's activity on hepatocyte has not been developed. In this study, a nontumor hepatic cell line HL7702 with HBX ectogenic expression has been established. MTT and BrdU assays showed that HBx promoted growth of HL7702 cells in vitro and downregulated activin signaling. Deregulated activin signaling pathway by HBX failed to activate target gene p21/waf1 and p15 transcription. In addition, mammalian two-hybrid and coimmunoprecipitation assays revealed that HBX could directly interact with activin signaling transduction protein Smad4, making activated Smad2/3/4 nucleus translocation suppressed. Furthermore, we detected that leptomycin B, the inhibitor of CRM1 protein, could recover nuclear translocation of endogenous Smads complex in HL7702 with HBX expression, indicating that HBX antagonized Smads nucleus translocation, at least partially, on CRM1-dependent manner. Leptomycin B was found to have antigrowth activity on HBX-expressed HL7702, according to its antitumor function in previous study. Above all, HBX antagonized activin signaling in normal human liver cells by interacting with Smad4 might one of the considerable causes of HBX-induced hepatocyte transformation, which deprived activin's cell growth inhibition function at an early stage of tumorigenesis.
Asunto(s)
Activinas/fisiología , Hepatocitos/fisiología , Carioferinas/fisiología , Receptores Citoplasmáticos y Nucleares/fisiología , Proteína Smad4/fisiología , Transactivadores/fisiología , Transporte Activo de Núcleo Celular , Proliferación Celular , Células Cultivadas , Humanos , Neoplasias Hepáticas/etiología , Proteínas Reguladoras y Accesorias Virales , Proteína Exportina 1RESUMEN
Rbx1 and Rbx2 are essential components of Cullin-RING E3 Ligases. Vif is generally believed to preferentially recruit the Cul5-Rbx2 module to induce proteasomal degradation of antiretroviral enzyme APOBEC3G, although some investigators have found that the Cul5-Rbx1 module is recruited. Here, to investigate the function of the two Rbx proteins in the Vif-Cul5 complex, we analyzed the performance of Cul5-Rbx1/Cul5-Rbx2 module in the activity of Vif E3 ligase and evaluated the interactions between Rbx1/Rbx2 and Cul5. We found that either Rbx1 or Rbx2 could promote ubiquitination of APOBE3G (A3G) in vitro. We also found that both Rbx1 and Rbx2 could bind Cul5 in cells and Rbx2 could dose-dependently inhibit the interaction of Rbx1 with Cul5. Furthermore, only the decrease of endogenous Rbx2 but not Rbx1 could impair the Vif-induced A3G degradation in cells. These findings indicate that Rbx1 and Rbx2 can both activate Cul5-Vif E3 ligase in vitro, but they may undergo a more delicate selection mechanism in vivo.
Asunto(s)
Proteínas Portadoras/química , Proteínas Portadoras/metabolismo , VIH-1/enzimología , Ubiquitina-Proteína Ligasas/química , Ubiquitina-Proteína Ligasas/metabolismo , Células HEK293 , Humanos , Complejos Multienzimáticos/química , Complejos Multienzimáticos/metabolismo , Ubiquitinación/fisiología , Productos del Gen vif del Virus de la Inmunodeficiencia Humana/química , Productos del Gen vif del Virus de la Inmunodeficiencia Humana/metabolismoRESUMEN
BACKGROUND: All lentiviruses except equine infectious anemia virus (EIVA) antagonize antiviral family APOBEC3 (A3) proteins of the host through viral Vif proteins. The mechanism by which Vif of human, simian or feline immunodeficiency viruses (HIV/SIV/FIV) suppresses the corresponding host A3s has been studied extensively. RESULTS: Here, we determined that bovine immunodeficiency virus (BIV) and maedi-visna virus (MVV) Vif proteins utilize the Cullin (Cul)-ElonginB (EloB)-ElonginC (EloC) complex (BIV Vif recruits Cul2, while MVV Vif recruits Cul5) to degrade Bos taurus (bt)A3Z2-Z3 and Ovis aries (oa)A3Z2-Z3, respectively, via a proteasome-dependent but a CBF-ß-independent pathway. Mutation of the BC box in BIV and MVV Vif, C-terminal hydrophilic replacement of btEloC and oaEloC and dominant-negative mutants of btCul2 and oaCul5 could disrupt the activity of BIV and MVV Vif, respectively. While the membrane-permeable zinc chelator TPEN could block BIV Vif-mediated degradation of btA3Z2-Z3, it had minimal effects on oaA3Z2-Z3 degradation induced by MVV Vif, indicating that Zn is important for the activity of BIV Vif but not MVV Vif. Furthermore, we identified a previously unreported zinc binding loop [C-x1-C-x1-H-x19-C] in the BIV Vif upstream BC box which is critical for its degradation activity. CONCLUSIONS: A novel zinc binding loop was identified in the BIV Vif protein that is important for the E3 ubiquination activity, suggesting that the degradation of btA3Z2-Z3 by BIV and that of oaA3Z2-Z3 by MVV Vif may need host factors other than CBF-ß.
Asunto(s)
Proteínas Cullin/fisiología , Citosina Desaminasa/metabolismo , Productos del Gen vif/fisiología , Interacciones Huésped-Patógeno , Virus de la Inmunodeficiencia Bovina/fisiología , Factores de Transcripción/fisiología , Ubiquitina-Proteína Ligasas/fisiología , Virus Visna-Maedi/fisiología , Desaminasas APOBEC , Animales , Citidina Desaminasa , Elonguina , Productos del Gen vif/química , Células HEK293 , Humanos , Complejo de la Endopetidasa Proteasomal/fisiologíaRESUMEN
BACKGROUND: The HIV-1 accessory factor Vif is necessary for efficient viral infection in non-permissive cells. Vif antagonizes the antiviral activity of human cytidine deaminase APOBEC3 proteins that confer the non-permissive phenotype by tethering them (APOBEC3DE/3F/3G) to the Vif-CBF-ß-ElonginB-ElonginC-Cullin5-Rbx (Vif-CBF-ß-EloB-EloC-Cul5-Rbx) E3 complex to induce their proteasomal degradation. EloB and EloC were initially reported as positive regulatory subunits of the Elongin (SIII) complex. Thereafter, EloB and EloC were found to be components of Cul-E3 complexes, contributing to proteasomal degradation of specific substrates. CBF-ß is a newly identified key regulator of Vif function, and more information is needed to further clarify its regulatory mechanism. Here, we comprehensively investigated the functions of EloB (together with EloC) in the Vif-CBF-ß-Cul5 E3 ligase complex. RESULTS: The results revealed that: (1) EloB (and EloC) positively affected the recruitment of CBF-ß to Vif. Both knockdown of endogenous EloB and over-expression of its mutant with a 34-residue deletion in the COOH-terminal tail (EloBΔC34/EBΔC34) impaired the Vif-CBF-ß interaction. (2) Introduction of both the Vif SLQ â AAA mutant (VifΔSLQ, which dramatically impairs Vif-EloB-EloC binding) and the Vif PPL â AAA mutant (VifΔPPL, which is thought to reduce Vif-EloB binding) could reduce CBF-ß binding. (3) EloB-EloC but not CBF-ß could greatly enhance the folding of full-length Vif in Escherichia coli. (4) The over-expression of EloB or the N-terminal ubiquitin-like (UbL) domain of EloB could significantly improve the stability of Vif/VifΔSLQ/VifΔPPL through the region between residues 9 and 14. CONCLUSION: Our results indicate that the Vif interaction with EloB-EloC may contribute to recruitment of CBF-ß to Vif, demonstrating that the EloB C-teminus may play a role in improving Vif function and that the over-expression of EloB results in Vif stabilization.
Asunto(s)
Subunidad beta del Factor de Unión al Sitio Principal/metabolismo , VIH-1/fisiología , Interacciones Huésped-Patógeno , Factores de Transcripción/metabolismo , Productos del Gen vif del Virus de la Inmunodeficiencia Humana/metabolismo , Línea Celular , Elonguina , Humanos , Unión Proteica , Mapeo de Interacción de ProteínasRESUMEN
The HIV-1 viral infectivity factor (Vif) protein is essential for viral replication. Vif recruits cellular ElonginB/C-Cullin5 E3 ubiquitin ligase to target the host antiviral protein APOBEC3G (A3G) for proteasomal degradation. In the absence of Vif, A3G is packaged into budding HIV-1 virions and introduces multiple mutations in the newly synthesized minus-strand viral DNA to restrict virus replication. Thus, the A3G-Vif-E3 complex represents an attractive target for development of novel anti-HIV drugs. In this study, we identified a potent small molecular compound (VEC-5) by virtual screening and validated its anti-Vif activity through biochemical analysis. We show that VEC-5 inhibits virus replication only in A3G-positive cells. Treatment with VEC-5 increased cellular A3G levels when Vif was coexpressed and enhanced A3G incorporation into HIV-1 virions to reduce viral infectivity. Coimmunoprecipitation and computational analysis further attributed the anti-Vif activity of VEC-5 to the inhibition of Vif from direct binding to the ElonginC protein. These findings support the notion that suppressing Vif function can liberate A3G to carry out its antiviral activity and demonstrate that regulation of the Vif-ElonginC interaction is a novel target for small-molecule inhibitors of HIV-1.
Asunto(s)
Antivirales/farmacología , Infecciones por VIH/metabolismo , VIH-1/fisiología , Bibliotecas de Moléculas Pequeñas/farmacología , Factores de Transcripción/metabolismo , Replicación Viral/efectos de los fármacos , Productos del Gen vif del Virus de la Inmunodeficiencia Humana/metabolismo , Desaminasa APOBEC-3G , Línea Celular , Citidina Desaminasa/genética , Citidina Desaminasa/metabolismo , Evaluación Preclínica de Medicamentos , Elonguina , Infecciones por VIH/genética , Infecciones por VIH/virología , VIH-1/efectos de los fármacos , VIH-1/genética , Humanos , Unión Proteica/efectos de los fármacos , Factores de Transcripción/genética , Productos del Gen vif del Virus de la Inmunodeficiencia Humana/genéticaRESUMEN
Tetherin/BST-2/CD317 inhibits HIV-1 release from infected cells, while HIV-1 Vpu efficiently antagonizes tetherin based on intermolecular interactions between the transmembrane domains of each protein. In this study, we successfully partially purified His-tagged tetherin with a glycophosphatidylinositol deletion (delGPI) and His-tagged full-length Vpu from transiently transfected 293T cells using affinity chromatography. The in vitro interaction between these purified proteins was observed by a pull-down assay and ELISA. Detection of the Vpu/tetherin interaction by ELISA is a novel approach that would be advantageous for inhibitor screening in vitro. Successful co-purification of the tetherin/Vpu complex also provides a basis for further structural studies.
Asunto(s)
Antígenos CD/aislamiento & purificación , Antígenos CD/metabolismo , Proteínas del Virus de la Inmunodeficiencia Humana/aislamiento & purificación , Proteínas del Virus de la Inmunodeficiencia Humana/metabolismo , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Proteínas Reguladoras y Accesorias Virales/aislamiento & purificación , Proteínas Reguladoras y Accesorias Virales/metabolismo , Antígenos CD/química , Antígenos CD/genética , Cromatografía de Afinidad , Clonación Molecular , Ensayo de Inmunoadsorción Enzimática/métodos , Proteínas Ligadas a GPI/química , Proteínas Ligadas a GPI/genética , Proteínas Ligadas a GPI/aislamiento & purificación , Proteínas Ligadas a GPI/metabolismo , Células HEK293 , Proteínas del Virus de la Inmunodeficiencia Humana/química , Proteínas del Virus de la Inmunodeficiencia Humana/genética , Humanos , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Reguladoras y Accesorias Virales/química , Proteínas Reguladoras y Accesorias Virales/genéticaRESUMEN
Various feline APOBEC3 (fA3) proteins exhibit broad antiviral activities against a wide range of viruses, such as feline immunodeficiency virus (FIV), feline foamy virus (FFV), and feline leukemia virus (FeLV), as well as those of other species. This activity can be counteracted by the FIV Vif protein, but the mechanism by which FIV Vif suppresses fA3s is unknown. In the present study, we demonstrated that FIV Vif could act via a proteasome-dependent pathway to overcome fA3s. FIV Vif interacted with feline cellular proteins Cullin5 (Cul5), ElonginB, and ElonginC to form an E3 complex to induce degradation of fA3s. Both the dominant-negative Cul5 mutant and a C-terminal hydrophilic replacement ElonginC mutant potently disrupted the FIV Vif activity against fA3s. Furthermore, we identified a BC-box motif in FIV Vif that was essential for the recruitment of E3 ubiquitin ligase and also required for FIV Vif-mediated degradation of fA3s. Moreover, despite the lack of either a Cul5-box or a HCCH zinc-binding motif, FIV Vif specifically selected Cul5. Therefore, FIV Vif may interact with Cul5 via a novel mechanism. These finding imply that SOCS proteins may possess distinct mechanisms to bind Cul5 during formation of the Elongin-Cullin-SOCS box complex.
Asunto(s)
Proteínas Cullin/metabolismo , Citosina Desaminasa/metabolismo , Síndrome de Inmunodeficiencia Adquirida del Felino/virología , Productos del Gen vif/metabolismo , Factores de Transcripción/metabolismo , Ubiquitina-Proteína Ligasas/metabolismo , Desaminasas APOBEC , Secuencia de Aminoácidos , Animales , Western Blotting , Gatos , Células Cultivadas , Proteínas Cullin/genética , Citidina Desaminasa , Citosina Desaminasa/genética , Elonguina , Síndrome de Inmunodeficiencia Adquirida del Felino/genética , Síndrome de Inmunodeficiencia Adquirida del Felino/metabolismo , Productos del Gen vif/genética , Humanos , Virus de la Inmunodeficiencia Felina/genética , Inmunoprecipitación , Datos de Secuencia Molecular , Mutación/genética , Plásmidos , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Homología de Secuencia de Aminoácido , Factores de Transcripción/genética , Ubiquitina-Proteína Ligasas/genéticaRESUMEN
Two kinds of Gemini surfactant monolayer, which showed different hydrophobic property, were selected as adsorption substrates for collagen. The topographic images of collagen were investigated by using an atomic force microscopy (AFM). Their auto-organized nano-structures were influenced by the property of substrate and the process of sample preparation, such as concentration of collagen solution, adsorption time and drying condition. Network-like structures formed on the both Gemini monolayers. With increasing concentration of collagen solution and adsorption time, the density of the network-like structure increased and their strands became wider and the mesh sizes decreased apparently. Contrary to the reference, the network-like structures of collagen also formed on the less hydrophobic Gemini surfactant monolayer even after very short adsorption time, which was considered to result from the more hydrophobic patch on it.
Asunto(s)
Colágeno/química , Colágeno/ultraestructura , Nanoestructuras/química , Tensoactivos/química , Adsorción , Animales , Bovinos , Interacciones Hidrofóbicas e Hidrofílicas , Microscopía de Fuerza Atómica , Soluciones , Factores de TiempoRESUMEN
BST-2/tetherin blocks the release of various enveloped viruses including HIV-1 with a "physical tethering" model. The detailed contribution of N-linked glycosylation to this model is controversial. Here, we confirmed that mutation of glycosylation sites exerted an effect of post-translational mis-trafficking, leading to an accumulation of BST-2 at intracellular CD63-positive vesicles. BST-2 with this phenotype potently inhibited the release of multivesicular body-targeted HIV-1 and hepatitis B virus, without affecting the co-localization of BST-2 with EEA1 and LAMP1. These results suggest that N-linked glycosylation of human BST-2 is dispensable for intracellular virion retention and imply that this recently discovered intracellular tethering function may be evolutionarily distinguished from the canonical antiviral function of BST-2 by tethering nascent virions at the cell surface.
Asunto(s)
Antígenos CD/metabolismo , VIH-1/inmunología , Virus de la Hepatitis B/inmunología , Cuerpos Multivesiculares/inmunología , Cuerpos Multivesiculares/virología , Proteínas Mutantes/metabolismo , Mutación , Antígenos CD/genética , Línea Celular , Células Epiteliales/inmunología , Células Epiteliales/virología , Proteínas Ligadas a GPI/genética , Proteínas Ligadas a GPI/metabolismo , Glicosilación , Hepatocitos/inmunología , Hepatocitos/virología , Humanos , Cuerpos Multivesiculares/química , Proteínas Mutantes/genética , Tetraspanina 30/análisisRESUMEN
BST-2/tetherin is an interferon-inducible antiviral protein that blocks the release of various enveloped viruses, including HIV-1. Hepatitis B virus (HBV), a major cause of liver disease, belongs to the Hepadnaviridae family of enveloped DNA viruses. Whether BST-2 regulates HBV production is largely unknown. In this report, we have demonstrated that HBV particle release is modulated by BST-2 in a cell type-dependent fashion. In HEK293T cells, ectopically expressed or interferon-induced BST-2 strongly inhibited HBV release. BST-2 co-localized with HBV surface protein at multivesicular bodies (MVBs) and physically interacted with HBV particles. However, exogenous BST-2-induced HBV restriction was weak in Huh-7 hepatoma cells, and the interferon-induced anti-HBV effect was independent of BST-2 induction in hepatic L02 cells. Notably, HBV could promote HIV-1 ΔVpu virus release from BST-2-positive HepG2 hepatoma cells but not HeLa cells, whereas Vpu failed to efficiently inhibit BST-2-induced HBV restriction. HBx exhibited an enhanced interaction and co-localization with BST-2 in hepatocytes. These observations indicate that BST-2 restricts HBV production at intracellular MVBs but is inactivated by HBV through a novel mechanism requiring hepatocyte-specific cellular co-factors or a hepatocyte-specific environment. Further understanding of BST-2-induced HBV restriction may provide new therapeutic targets for future HBV treatments.
Asunto(s)
Antígenos CD/metabolismo , Virus de la Hepatitis B/fisiología , Hepatocitos/metabolismo , Hepatocitos/virología , Compartimento Celular , Línea Celular Tumoral , Proteínas Ligadas a GPI/metabolismo , Antígenos de Superficie de la Hepatitis B/inmunología , Proteínas del Virus de la Inmunodeficiencia Humana/metabolismo , Humanos , Modelos Biológicos , Mutación/genética , Unión Proteica , Transporte de Proteínas , Tetraspanina 30/metabolismo , Transactivadores/metabolismo , Proteínas Reguladoras y Accesorias Virales/metabolismo , Virión/metabolismoRESUMEN
BST-2 blocks the particle release of various enveloped viruses including HIV-1, and this antiviral activity is dependent on the topological arrangement of its four structural domains. Several functions of the cytoplasmic tail (CT) of BST-2 have been previously discussed, but the exact role of this domain remains to be clearly defined. In this study, we investigated the impact of truncation and commonly-used tags addition into the CT region of human BST-2 on its intracellular trafficking and signaling as well as its anti-HIV-1 function. The CT-truncated BST-2 exhibited potent inhibition on Vpu-defective HIV-1 and even wild-type HIV-1. However, the N-terminal HA-tagged CT-truncated BST-2 retained little antiviral activity and dramatically differed from its original protein in the cell surface level and intracellular localization. Further, we showed that the replacement of the CT domain with a hydrophobic tag altered BST-2 function possibly by preventing its normal vesicular trafficking. Notably, we demonstrated that a positive charged motif "KRXK" in the conjunctive region between the cytotail and the transmembrane domain which is conserved in primate BST-2 is important for the protein trafficking and the antiviral function. These results suggest that although the CT of BST-2 is not essential for its antiviral activity, the composition of residues in this region may play important roles in its normal trafficking which subsequently affected its function. These observations provide additional implications for the structure-function model of BST-2.
Asunto(s)
Antígenos CD/metabolismo , Epítopos/metabolismo , VIH-1/fisiología , Secuencia de Aminoácidos , Animales , Antígenos CD/química , Células COS , Chlorocebus aethiops , Proteínas Ligadas a GPI/química , Proteínas Ligadas a GPI/metabolismo , Células HEK293 , Humanos , Datos de Secuencia Molecular , Señales de Clasificación de Proteína , Estructura Terciaria de Proteína , Transporte de ProteínasRESUMEN
Tetherin/BST-2/CD317 inhibits HIV-1 release from infected cells, but the viral Vpu protein efficiently antagonizes this antiviral activity through direct interaction between the transmembrane (TM) domains of each protein. Here, we demonstrated that overexpression of an inactive tetherin delGPI mutant, the TM domain of which could competitively block Vpu targeting of endogenous tetherin, potently inhibited HIV-1 release from human tetherin-positive cells in both transient and stable expression conditions. These results also suggest that heterologous dimerization occurred between the delGPI mutant and endogenous tetherin. These findings suggest that blocking the Vpu/tetherin interface may be a novel therapeutic approach against HIV-1 release.
Asunto(s)
Antígenos CD/biosíntesis , VIH-1/metabolismo , Proteínas del Virus de la Inmunodeficiencia Humana/metabolismo , Proteínas Mutantes/biosíntesis , Eliminación de Secuencia , Proteínas Reguladoras y Accesorias Virales/metabolismo , Antígenos CD/genética , Antígenos CD/metabolismo , Estudios de Factibilidad , Proteínas Ligadas a GPI/antagonistas & inhibidores , Proteínas Ligadas a GPI/biosíntesis , Proteínas Ligadas a GPI/genética , Proteínas Ligadas a GPI/metabolismo , Terapia Genética , Glicosilfosfatidilinositoles/metabolismo , Células HEK293 , Infecciones por VIH/terapia , VIH-1/patogenicidad , Células HeLa , Humanos , Microscopía Fluorescente , Proteínas Mutantes/antagonistas & inhibidores , Proteínas Mutantes/metabolismo , Ingeniería de Proteínas , Dominios y Motivos de Interacción de Proteínas , Estabilidad Proteica , Transporte de Proteínas , Proteínas Recombinantes/antagonistas & inhibidores , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/metabolismo , Virión/metabolismo , Virión/patogenicidad , Liberación del VirusRESUMEN
Tetherin (BST-2/CD317) is an interferon-inducible antiviral protein that restricts the release of enveloped viruses from infected cells. The HIV-1 accessory protein Vpu can efficiently antagonize this restriction. In this study, we analyzed mutations of the transmembrane (TM) domain of Vpu, including deletions and substitutions, to delineate amino acids important for HIV-1 viral particle release and in interactions with tetherin. The mutants had similar subcellular localization patterns with that of wild-type Vpu and were functional with respect to CD4 downregulation. We showed that the hydrophobic binding surface for tetherin lies in the core of the Vpu TM domain. Three consecutive hydrophobic isoleucine residues in the middle region of the Vpu TM domain, I15, I16 and I17, were important for stabilizing the tetherin binding interface and determining its sensitivity to tetherin. Changing the polarity of the amino acids at these positions resulted in severe impairment of Vpu-induced tetherin targeting and antagonism. Taken together, these data reveal a model of specific hydrophobic interactions between Vpu and tetherin, which can be potentially targeted in the development of novel anti-HIV-1 drugs.
Asunto(s)
Antígenos CD/metabolismo , Membrana Celular , VIH-1 , Proteínas del Virus de la Inmunodeficiencia Humana/química , Proteínas del Virus de la Inmunodeficiencia Humana/metabolismo , Proteínas Reguladoras y Accesorias Virales/química , Proteínas Reguladoras y Accesorias Virales/metabolismo , Secuencia de Aminoácidos , Fármacos Anti-VIH/farmacología , Antígenos CD4/metabolismo , Regulación hacia Abajo , Estudios de Factibilidad , Proteínas Ligadas a GPI/metabolismo , Células HEK293 , VIH-1/efectos de los fármacos , VIH-1/fisiología , Células HeLa , Proteínas del Virus de la Inmunodeficiencia Humana/genética , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Datos de Secuencia Molecular , Mutagénesis , Mutación , Unión Proteica/efectos de los fármacos , Unión Proteica/genética , Estructura Terciaria de Proteína , Relación Estructura-Actividad , Proteínas Reguladoras y Accesorias Virales/genética , Liberación del Virus/genéticaRESUMEN
The self-assembly nano-structures of type I collagen adsorbed on anionic Gemini surfactant LB monolayer were observed by using atomic force microscopy (AFM) images. It was found that the adsorption behavior and self-assembly structure of collagen could be controlled by the concentration of the collagen solution, adsorption interval and the properties of substrates. With the increase of the adsorption interval and concentration of collagen, the strands size of collagen changed. The self-assembly structures of collagen were also influenced by the interaction between collagen molecules and Gemini surfactant monolayer substrates. Finally, the adsorption behaviors of collagen molecules on cationic Gemini monolayer were compared with those on anionic Gemini monolayer.